Reading Time: 2 minutesThe Preclinical and Prodromal ALS session focused on early diagnosis of MND and the use of biomarkers to reveal early signs of the disease. A key approach to this type of research is to use a
Search Results for: clinical trial
36th Symposium: San Diego Causes and disease mechanisms Markers of Disease Progression MND Research Models of MND Symposium Treatments
Finding new treatments for MND
Reading Time: 6 minutesThe global MND research community is once again preparing for one of the most anticipated events of the year—the 36th International Symposium on ALS/MND. This annual
Reading Time: 5 minutesIn our previous blog, we took a walk through the early stages of the research journey, learning how researchers discover new things about MND and
Reading Time: 7 minutesHave you ever wondered what life in the lab really looks like? Who are the people working tirelessly to understand MND and find effective treatments
Reading Time: 5 minutesBy Oscar Wilkins, Non-Clinical Research Fellow, University College London and The Francis Crick Institute Hi, I’m Oscar, a newly appointed Lady Edith Wolfson Non-Clinical Research
Reading Time: 6 minutesMND EnCouRage UK is our annual event which aims to celebrate and support the work of researchers who are just beginning their careers in MND,
Reading Time: 7 minutesIn our previous blog, we explained what biomarkers are and what they can be used for. In this blog, we dive further into the world
Reading Time: 6 minutesMND doesn’t just affect movement – it can also impact thinking and behaviour. But these cognitive changes in MND aren’t the same for everyone. In
Reading Time: 5 minutesIn December 2024, we organised the 35th International Symposium on ALS/MND in Montreal, Canada. The International Symposium brings together researchers, healthcare professionals and people with and
Reading Time: 6 minutesWe organised the 35th International Symposium on ALS/MND in Montreal, Canada, back in December last year. The symposium provided an opportunity for researchers, clinicians and